
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.04 | 0.15 | 0.11 |
Stocks | 97.81 | 97.81 | 0.00 |
Other | 2.16 | 2.33 | 0.17 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 17.03 | 19.16 |
Price to Book | 4.50 | 4.43 |
Price to Sales | 3.61 | 2.56 |
Price to Cash Flow | 13.97 | 17.05 |
Dividend Yield | 1.02 | 1.09 |
5 Years Earnings Growth | 16.49 | 13.14 |
Number of long holdings: 185
Number of short holdings: 2
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
AbbVie | US00287Y1091 | 13.66 | 200.56 | +1.63% | |
Amgen | US0311621009 | 7.26 | 295.21 | +0.32% | |
Krystal Biotech | US5011471027 | 6.92 | 182.04 | +3.33% | |
Vertex | US92532F1003 | 4.49 | 479.21 | +1.58% | |
Regeneron Pharma | US75886F1075 | 3.98 | 693.70 | +1.30% | |
Gilead | US3755581036 | 3.60 | 109.51 | +1.73% | |
Alnylam | US02043Q1076 | 3.60 | 251.19 | +0.27% | |
UCB | BE0003739530 | 2.50 | 179.50 | -0.28% | |
argenx ADR | US04016X1019 | 2.49 | 647.34 | +1.12% | |
Ascendis Pharma AS | US04351P1012 | 2.14 | 154.70 | -0.26% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fidelity 500 Index Institutional Pr | 638.76B | 2.78 | 11.89 | 13.75 | ||
Fidelity Contrafund | 128.94B | 5.42 | 16.00 | 16.05 | ||
Fidelity Contrafund K | 128.94B | 5.45 | 16.08 | 16.15 | ||
Fidelity Total Market Index Instl b | 108.28B | 3.06 | 11.30 | 13.16 | ||
Fidelity Blue Chip Growth | 68.75B | 2.25 | 15.58 | 18.45 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review